Target intelligence / Profile preview

ATP-sensitive potassium channel, pancreatic beta cell type (K_ATP channel (beta cell))

Target
K_ATP channel (beta cell)
Molecular classification
Ion channel, Transporter (SUR1 subunit is an ABC transporter), Receptor (SUR1 subunit is the binding site for sulfonylureas)
01

Overview

The ATP-sensitive potassium channel (K_ATP channel) in pancreatic beta cells regulates insulin secretion in response to blood glucose levels. It is a hetero-octamer comprised of four pore-forming Kir6.2 subunits and four regulatory SUR1 subunits. Sulfonylurea drugs treat type 2 diabetes by binding to SUR1, causing channel closure, cell membrane depolarization, calcium influx, and subsequent insulin secretion. Prolonged or excessive activation can lead to secondary drug failure or resistance, and the principal safety concern is increased risk of hypoglycemia, particularly in patients with fragile glycemic control[2][3][4][6][8]. This target is central to the pharmacological management of diabetes but is not a 'receptor' in the classical sense—instead, it is a drug-regulated ion channel complex.

Other names
ATP-sensitive potassium channelK_ATP channelSulfonylurea receptor channelKir6.2/SUR1 channel
02

Mechanism of action

Sulfonylureas bind to the SUR1 subunit, closing the K_ATP channel. - Channel closure depolarizes beta cell membrane. - Depolarization opens voltage-dependent calcium channels, causing Ca²⁺ influx. - Intracellular calcium triggers insulin granule exocytosis[2][3][4][6][8].

03

Biological functions

Signal transductionRegulation of membrane potentialControl of insulin secretionGlucose homeostasis
04

Disease associations

Type 2 diabetes mellitusNeonatal diabetes (mutations)Hyperinsulinism (mutations)Drug-induced hypoglycemia
05

Safety considerations

Hypoglycemia (often severe)Secondary sulfonylurea failure (diminished efficacy over time)Weight gainRisk in elderly or renally impaired patients[6][8]
06

Interacting drugs

Glibenclamide

4 more in the full profile.

07

Biomarkers

Circulating insulin and C-peptide levelsBlood glucose level response following sulfonylurea administrationGenetic markers (mutations in KCNJ11 [Kir6.2] and ABCC8 [SUR1])[2][4]

Beyond the preview

Go deeper on ATP-sensitive potassium channel, pancreatic beta cell type (K_ATP channel (beta cell)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-sensitive potassium channel, pancreatic beta cell type (K_ATP channel (beta cell)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call